Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

302
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
302
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

604
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
604
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

150
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
150
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

893
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
893
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

209
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
209
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

534
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
534

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonlocal Metaspire: A Scalable Elastic Material Platform With Decoupled Mechanical Modes.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition.

The Korean journal of helicobacter and upper gastrointestinal research·2026
Same author

Nationwide Survey on Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea: Results From the Korean College of <i>Helicobacter</i> and Upper Gastrointestinal Research (KCHUGR) 2023 Survey.

Journal of gastric cancer·2026
Same author

Gastritis: Pathophysiology, Diagnosis, and Clinical Implications.

The Korean journal of helicobacter and upper gastrointestinal research·2026
Same author

Treatment of Helicobacter pylori Infection in Korea: An Evidence-Based Analysis of the Upcoming 2025 Guideline.

The Korean journal of helicobacter and upper gastrointestinal research·2026
Same author

Nationwide Survey on Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea: Results From the Korean College of Helicobacter and Upper Gastrointestinal Research (KCHUGR) 2023 Survey.

The Korean journal of helicobacter and upper gastrointestinal research·2026
Same journal

Barrett's Esophagus.

The Korean journal of helicobacter and upper gastrointestinal research..·2025
Same journal

Impact of Helicobacter pylori Screening on Gastric Cancer Incidence and Mortality.

The Korean journal of helicobacter and upper gastrointestinal research..·2025
Same journal

Series of Inadvertent Misplacements of Nasogastric Tube in a Patient.

The Korean journal of helicobacter and upper gastrointestinal research..·2025
Same journal

Changes in Helicobacter pylori Status in Patients Who Underwent Partial Gastrectomy for Gastric Cancer Therapy.

The Korean journal of helicobacter and upper gastrointestinal research..·2025
Same journal

Two Cases of Pneumothorax Induced by Fish Bones Impacted in the Esophagus.

The Korean journal of helicobacter and upper gastrointestinal research..·2025
Same journal

Treatment of Refractory Gastric Outlet Obstruction After Endoscopic Submucosal Dissection With Endoscopic Antralplasty and Stent Placement: A Case Report.

The Korean journal of helicobacter and upper gastrointestinal research..·2025
See all related articles

Related Experiment Video

Updated: Sep 18, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.7K

Peptic Ulcer Disease.

Seung Han Kim1

  • 1Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.

The Korean Journal of Helicobacter and Upper Gastrointestinal Research
|June 23, 2025
PubMed
Summary
This summary is machine-generated.

Peptic ulcer disease is still a concern due to Helicobacter pylori and NSAIDs. New treatments are needed as antibiotic resistance limits H. pylori eradication efficacy.

Keywords:
Antibiotic resistanceHelicobacter pyloriPeptic ulcer

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

501

Related Experiment Videos

Last Updated: Sep 18, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.7K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

501

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Peptic ulcer disease incidence and complications have decreased.
  • Helicobacter pylori infection and NSAID use are primary risk factors.
  • Proton pump inhibitors and potassium-competitive acid blockers have improved outcomes.

Purpose of the Study:

  • To review current risk factors and treatment outcomes for peptic ulcer disease.
  • To highlight challenges in H. pylori eradication due to antibiotic resistance.
  • To discuss emerging therapeutic strategies for peptic ulcer disease.

Main Methods:

  • Literature review of peptic ulcer disease epidemiology and treatment.
  • Analysis of the impact of antibiotic resistance on H. pylori eradication.
  • Evaluation of novel therapeutic approaches.

Main Results:

  • Standard H. pylori eradication therapies are becoming less effective.
  • Novel antibiotic combinations and bismuth-based regimens show promise.
  • Tailored strategies are essential to combat resistance.

Conclusions:

  • Despite advances, H. pylori resistance necessitates new treatment paradigms.
  • Innovative anti-ulcer therapies are crucial for improved eradication and prevention.
  • Future research should focus on personalized medicine for peptic ulcer disease.